Estratificação de Risco dos Doentes com Doença Hepática Crónica e Potenciais Implicações para o Plano de Vacinação COVID-19 em Portugal

Rui Tato Marinho; Leopoldo Matos; Guilherme Macedo

doi:10.20344/amp.16442

Risk Stratification of Patients with Chronic Liver Disease and Potential Implications for the COVID-19 Vaccination Program in Portugal

Authors

Rui Tato Marinho Diretor. Serviço de Gastrenterologia e Hepatologia. Centro Hospitalar Universitário Lisboa Norte (Hospital Santa Maria e Hospital Pulido Valente). Lisboa. Professor. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Presidente. Sociedade Portuguesa de Gastrenterologia. Lisboa. https://orcid.org/0000-0003-1327-3537
Leopoldo Matos Hepatologia. Ordem dos Médicos. Lisboa. Hospital dos Lusíadas. Lisboa.
Guilherme Macedo Diretor. Serviço de Gastrenterologia e Hepatologia. Centro Hospitalar Universitário S. João. Porto. Professor. Faculdade de Medicina. Universidade do Porto. Porto. Vice Presidente. Sociedade Portuguesa de Gastrenterologia. Lisboa.

DOI:

https://doi.org/10.20344/amp.16442

Keywords:

COVID-19 Vaccines, Immunization Programs, Liver Cirrhosis, Liver Diseases

Abstract

N/a.

Downloads

Download data is not yet available.

Downloads

PDF (Português)

Published

2021-06-01

How to Cite

Tato Marinho R, Matos L, Macedo G. Risk Stratification of Patients with Chronic Liver Disease and Potential Implications for the COVID-19 Vaccination Program in Portugal. Acta Med Port [Internet]. 2021 Jun. 1 [cited 2024 Nov. 23];34(6):489-90. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/16442

Download Citation

Issue

Vol. 34 No. 6 (2021): June

Section

Letters to the Editor

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.